Abstract:
The aim of the project is to secure funding for key steps leading to the commercialization of newly developed compounds RuTDG and BuRuTDG, which show high potential for targeted treatment of aggressive forms of breast cancer. The project will enable the patent to enter national phases and the preparation of a spin-off company, thereby creating a bridge between the results of basic research and their practical application.